| RS2530291651 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2530298654 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Dilated cardiomyopathy 1G |
| RS2530303960 |
UBA5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 44 |
| RS2530304011 |
UBA5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 44 |
| RS2530309710 |
MSH6
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530312249 |
ANKRD17
|
Health Risk |
Pathogenic |
Chopra-Amiel-Gordon syndrome, Chopra-Amiel-Gordon syndrome |
| RS2530313245 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530313356 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530313399 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2530315359 |
UBA5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2530316357 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530316392 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530316491 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530316549 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530316571 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530316618 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530316752 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530317186 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2530317695 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530317763 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS2530318029 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |
| RS2530318204 |
MSH6
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome 5, Endometrial carcinoma |
| RS2530318416 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530318697 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 5 |
| RS2530319288 |
MSH6
|
Health Risk |
Pathogenic |
Inherited MMR deficiency (Lynch syndrome), Inherited MMR deficiency (Lynch syndrome) |
| RS2530319597 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS2530319768 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |
| RS2530319897 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530319996 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530320026 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530320378 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530320822 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |
| RS2530321671 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |
| RS2530323486 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530325660 |
UBA5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 44 |
| RS2530332377 |
UBA5
|
Health Risk |
Pathogenic |
— |
| RS2530334697 |
SCLT1
|
Health Risk |
Pathogenic |
— |
| RS2530351536 |
NAA15
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2530351729 |
NAA15
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2530358034 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2530360005 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530362767 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530362884 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530363576 |
MCCC1
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530363751 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2530363834 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530368656 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2530368695 |
NAA15
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2530368724 |
NAA15
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intellectual disability |
| RS2530368862 |
NAA15
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2530368885 |
PROM1
|
Health Risk |
Likely pathogenic |
— |
| RS2530371465 |
STAG1
|
Health Risk |
Pathogenic |
— |
| RS2530372155 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530372828 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS2530374916 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2530375232 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2530375400 |
NAA15
|
Health Risk |
Pathogenic |
— |
| RS2530376896 |
NPHP3
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Renal-hepatic-pancreatic dysplasia 1 |
| RS2530377308 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2530379124 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2530379181 |
NAA15
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2530380429 |
NPHP3
|
Health Risk |
Likely pathogenic |
Renal-hepatic-pancreatic dysplasia 1, Renal-hepatic-pancreatic dysplasia 1 |
| RS2530385906 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2530385996 |
NPHP3
|
Health Risk |
Likely pathogenic |
NPHP3-related disorder, NPHP3-related disorder |
| RS2530391608 |
NAA15
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2530391766 |
NAA15
|
Health Risk |
Pathogenic |
— |
| RS2530392269 |
MED12L
|
Health Risk |
Likely pathogenic |
Nizon-Isidor syndrome, Nizon-Isidor syndrome |
| RS2530394726 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2530394997 |
STAG1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 47 |
| RS2530396115 |
NAA15
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2530396336 |
NAA15
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2530396366 |
NAA15
|
Health Risk |
Likely pathogenic |
— |
| RS2530397425 |
NAA15
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2530397518 |
NAA15
|
Health Risk |
Pathogenic |
— |
| RS2530398321 |
STAG1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 47 |
| RS2530401396 |
NPHP3
|
Health Risk |
Likely pathogenic |
NPHP3-related disorder, NPHP3-related disorder |
| RS2530403226 |
SCLT1
|
Health Risk |
Pathogenic |
— |
| RS2530403268 |
NAA15
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2530411057 |
NAA15
|
Health Risk |
Pathogenic |
— |
| RS2530411068 |
NAA15
|
Health Risk |
Likely pathogenic |
— |
| RS2530411207 |
NAA15
|
Health Risk |
Pathogenic |
— |
| RS2530411290 |
NAA15
|
Health Risk |
Likely pathogenic |
— |
| RS2530415049 |
RPL35A
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia, Diamond-Blackfan anemia 5 |
| RS2530415161 |
RPL35A
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 5, Diamond-Blackfan anemia 5 |
| RS2530415541 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS2530418752 |
NAA15
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2530418844 |
NAA15
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2530418866 |
NAA15
|
Health Risk |
Likely pathogenic |
NAA15-related disorder, NAA15-related disorder |
| RS2530418923 |
NAA15
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2530419555 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS2530421661 |
NAA15
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS2530424559 |
FAT4
|
Health Risk |
Likely pathogenic |
FAT4-related disorder, FAT4-related disorder |
| RS2530428521 |
SCLT1
|
Health Risk |
Likely pathogenic |
— |
| RS2530429152 |
FAT4
|
Health Risk |
Pathogenic |
— |
| RS2530430943 |
RPL35A
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2530431138 |
MSH6
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530431213 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS2530431324 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS2530431905 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2530432845 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |